INTEGRATED BIOPHARMA INC - FORM 10-K - EX-23.1 - EXHIBIT 23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - September 23, 2020

Attached files

file filename
EX-32.2 - EXHIBIT 32.2 CERTIFICATION OF CFO PURSUANT TO 18 USC - INTEGRATED BIOPHARMA INCex_202529.htm
EX-32.1 - EXHIBIT 32.1 CERTIFICATION OF CEO PURSUANT TO 18 USC - INTEGRATED BIOPHARMA INCex_202528.htm
EX-31.2 - EXHIBIT 31.2 CERTIFICATION OF CFO - INTEGRATED BIOPHARMA INCex_202527.htm
EX-31.1 - EXHIBIT 31.1 CERTIFICATION OF CEO - INTEGRATED BIOPHARMA INCex_202526.htm
EX-10.221 - EXHIBIT 10.22.1 AMENDMENT TO PAYCHECK PROTECTION PROGRAM TERM NOTE - INTEGRATED BIOPHARMA INCex_204539.htm
EX-21 - EXHIBIT 21 SUBSIDIARIES OF THE REGISTRANT - INTEGRATED BIOPHARMA INCex_202531.htm
10-K - FORM 10-K - INTEGRATED BIOPHARMA INCinbp20200630_10k.htm

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

We have issued our report dated September 23, 2020, with respect to the consolidated financial statements included in the Annual Report of Integrated Biopharma, Inc. on Form 10-K for the years ended June 30, 2020 and June 30, 2019. We hereby consent to the incorporation by reference of said report in the Registration Statements of Integrated BioPharma, Inc. on Forms S-8 (Nos. 333-229069, 333-37509, 333-87456 and 333-87458) and the Registration Statements on Forms S-3 (Nos. 333-144155 and 333-149855).

 

 

/s/ Friedman LLP

East Hanover, New Jersey

September 23, 2020

 

Stock widget

Investing forum

INTEGRATED BIOPHARMA INC Reports